Posts Tagged ‘RSV’

June 21, 2013

Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.


Warning: Invalid argument supplied for foreach() in /nfs/c04/h02/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h02/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h02/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177
.   .   

In both HSCT and SOT (especially lung transplants), RSV infections carry a high risk of morbidity and mortality. Ribavirin has been used for the treatment of RSV; however, it is unclear whether ribavirin is best given orally, intravenously, or by aerosolization. Aerosolized ribavirin is teratogenic and requires administration in a negative pressure room. Therefore, many […]

No Comments Posted in Transplant Infectious Disease